The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
March 26th 2024
The FDA identified high concentration of lidocaine across marketed, over-the-counter topical products from 6 different companies.
The Latest on Acute Lymphocytic Leukemia
View More
A Focus on Acute Myeloid Leukemia
View More
Updates in Myelodysplastic Syndromes
View More
Earn CME Credits While Advancing Your Expertise in Internal Medicine
April 18-19, 2024
Register Now!
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?
View More
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer
View More
Medical Crossfire®: Exchange Between Onco-Nursing Experts on MPN Treatment and Symptom Management Along the Care Continuum
View More
Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
Community Practice Connections™: 16th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Go To PER in Chicago
May 31, 2024 - June 2, 2024
Register Now!
The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward
View More
Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients with Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment
View More
Expert Illustrations & Commentaries™: Exploring the Mechanistic Rationale for Targeting FGFR2 and Pan-FGFR in CCA
View More
Expert Illustrations and Commentaries™: Emerging Therapies and Treatment Strategies to Improve Care for Your Patients with Anemia in CKD
View More
Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician
View More
Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC
View More
Medical Crossfire®: Leveraging Multidisciplinary Teams in Early–Stage Breast Cancer When the Goal is Cure
View More
Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target
View More
The 14th Asia-Pacific Primary Liver Cancer Expert Meeting
July 18 - 20, 2024
Register Now!
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
The Cleveland Clinic Fails to Recoup its $100 Million Investment
December 3rd 2009For those interested in health information technology, there is now an excellent, new, powerful website about this topic called the Huffington Post Investigative Fund. In their most recent report, "Can Cleveland Clinic Be a Model for Digital Medicine?" they discuss how this hospital system has failed to recoup their $100 million investment to date.
Is the HITECH Act Unconstitutional? - Part 2
December 2nd 2009Some pundits have written that health insurance mandates are well beyond the constitutional authority of the federal government to tax, spend, and regulate interstate commerce. Others have picked up on these arguments and applied them to the EHR-implementation incentives under the HITECH Act as well. The bottom line is that these arguments fail, for four reasons.
Is the HITECH Act Unconstitutional? - Part 1
December 2nd 2009There has been much discussion about the HITECH Act and the effects it will have on healthcare in this country. The health IT industry and the federal government claim that EHR use will lead to a decrease in costs and an overall improvement in patient care. Skeptics like me disagree with these claims and feel that the push to adopt complex EHRs will be a bad deal for physicians.
Translating Education into Clinical Practice: The Role of Learning Communities
November 24th 2009Collaboration is important in healthcare, as evidenced by the growing number of "learning communities" and grassroots efforts that are bringing people and organizations together to work on the issue of eliminating disparities in health and healthcare.
Vioxx Adverse Events May Have Been Identified Years Earlier
November 23rd 2009As of December 2000, 21 of 30 randomized, placebo-controlled trials had been completed and the risk of a cardiovascular thromboembolic adverse event or death was greater among subjects assigned to the rofecoxib group, raising concerns from a safety standpoint.
The Patient-centered Approach to Urine Drug Testing in the Chronic Pain Patient
November 12th 2009At PAINWeek 09, Howard Heit, MD, FACP, FASAM, began his presentation "The Patient-centered Approach to Urine Drug Testing in the Chronic Pain Patient" by briefly discussing the concept of Universal Precautions in pain medicine, noting that the term originated from the infectious disease model.
The pundits are going to have their field day with this one. "The danger [with this Bill] is that as costs continue to rise and coverage becomes less comprehensive, people will conclude that we've tried health reform and it didn't work. But the real problem will be that we didn't really try it.
VA Grant Spurs Development of Therapy for Neuropathic Pain
November 10th 2009A $1.8 million grant will help the University of Michigan investigate the use of herpes simplex virus-based vectors to deliver genes to sensory nerves from application in the skin, which researchers believe hold promise not only for the treatment of pain but also ultimately for the treatment of peripheral neuropathy itself.